МедФарм

@medpharm · health · Russian · active

Subscribers 12.1K tracking since 13 Nov
Reach per post (ERR) 4.6%558 avg views
Posting 15.2/day last 10 hours ago
Reactions per 1K views 0.4 ❤ 👍 😱
viral · 6.8× typical

Минздрав РФ зарегистрировал первый в России противоопухолевый препарат с МНН нимотузумаб. Он предназначен для лечения глиобластомы, рака пищевода и опухолей головы и шеи. МедФарм в Макс

Views over time

01K2K3K4K16 Oct 15:1913 Nov 00:193.5K16 Oct 15:19: 0 views13 Nov 00:19: 3,530 views
Snapshots we took after posting.
WhenViews
16 Oct 2026, 15:190
13 Nov 2026, 00:193.5K

Who shared this post

Posts in other channels we index that link to this one. (Forwards with a hidden source can't be traced.)

Nobody yet.